Found: 4
Select item for more details and to access through your institution.
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0599-z
- By:
- Publication type:
- Article
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0555-y
- By:
- Publication type:
- Article
The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0517-x
- By:
- Publication type:
- Article
miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 571, doi. 10.2147/OTT.S152611
- By:
- Publication type:
- Article